Tuesday, May 23, 2017

Tag: corruption

Potential Dangers and Dubious History of Alternative Medicine

From MinnPost: Two recent articles have exposed some of the potentially dangerous effects of alternative treatments including homeopathy and acupuncture, as well as corruption in...

Patient Advocacy Groups Accept Drug Industry Funds

From The New York Times: A new study has found that more than 80 percent of the nation's patient advocacy groups accept funding from drug...

“A Frenzy Of Lobbying On 21st Century Cures”

Kaiser Health News and NPR report on the immense lobbying effort aimed at passing the "21st Century Cures" Act which would fast-track FDA approval...

“Feds Charge Former Valeant and Philidor Execs with Fraud”

“The executive who once ran the specialty pharmacy at the heart of the Valeant Pharmaceutical accounting scandal was arrested Thursday morning, along with a...

“Former FDA Official Settles Insider Trading Charges”

For STAT, Ed Silverman reports that Gordon Johnston, a former FDA official, has agreed to a settlement after being accused of insider trading. “Johnston,...

“Drugs, Greed and a Dead Boy”

New York Times columnist, Nicholas Kristof, relates the story of Andrew Francesco, a boy who began taking Ritalin at age five and died from complications with Seroquel when he was fifteen. His father, a former pharmaceutical industry executive, reveals the industry’s greed in his memoir “Overmedicated and Undertreated.” Now the industry is pushing for a first-amendment right to market its drugs for off-label uses.

Massive Number of Antidepressant Meta-Analyses Biased By Industry

A massive number of meta-analyses of antidepressant clinical trials have financial conflicts of interest and are unduly influenced by pharmaceutical companies, according to a review to be published in an upcoming issue of the Journal of Clinical Epidemiology. Researchers also found that meta-analyses with industry ties almost never report any negative findings in their abstracts.

“Many Antidepressant Studies Found Tainted by Pharma Company Influence”

The Scientific American reports on a new analysis of antidepressant trials revealing that the vast majority of meta-analyses have industry links and suppress negative results.

The Road to Perdition

The recent research scandals out of the University of Minnesota’s Department of Psychiatry may be alarming, but they are not new. Back in the 1990s, when the university was working its way towards a crippling probation by the National Institutes of Health (for yet another episode of misconduct (this time in the Department of Surgery), the Department of Psychiatry hosted two spectacular cases of research wrongdoing, both of which resulted in faculty members being disqualified from conducting research by the FDA.

Follow Us

17,913FansLike
9,397FollowersFollow
1,229SubscribersSubscribe